Now showing items 1-1 of 1
99mTc sestamibi as a prognostic factor of response to first-line therapy and outcome in patients with malignant lymphoma
INTRODUCTION: Resistance to chemotherapy poses a major problem in cancer patients. Although of multifactorial origin, some of the implicated mechanisms also interfere with Tc-MIBI uptake and retention in cancer cells. The ...